Cite
HARVARD Citation
Griesel, R. et al. (2022). Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clinical infectious diseases. p. 755. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Griesel, R. et al. (2022). Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clinical infectious diseases. p. 755. [Online].